Dell, Inc. (NASDAQ: DELL) has rolled out what it is calling a "budget supercomputer" in a London event. The computer maker wants its newer and cheaper supercomputer offering to be used in research dealing with custom cures for cancer as well as searching for universe origins in all the radio wave data that spills into the earth these days using large collection dishes.
Is this a move into a new area of computing or a publicity stunt? Neither, but it is Dell's attempt at some good press, something that has been lacking for the company in recent years. With commodity computer parts available to just about anyone who wants them, Dell will once again be assembling commodity machines (supercomputers) to sell to large clients that need a lot of processing power to sift through all the data available to them. Dell's entrance (if it can be called that) is not really all that unexpected, as both competitors Hewlett-Packard Company (NYSE: HPQ) and Sun Microsystems, Inc. (NASDAQ: JAVA) have been in the supercomputer field for a very long time. Google, Inc. (NASDAQ: GOOG) made the practice of stringing together many standard PCs to make a supercomputer popular years ago as well.
Dell's new 'Legion' system will have the processing power of 3,000 desktop PCs and will target those who need cheap computing power available from commodity components without spending a fortune on proprietary systems and parts in the process. As Dell basically defined the role of commodity computer supplier in the last decade and a half, it should be primed to fill this role while giving in to the need of "adding value" to what could be seen as a boring commodity market. If Dell can bring more and more cheap supercomputing to the field and compete against International Business Machines Corp. (NYSE: IBM) (which leads all others when it comes to built supercomputers), then it may just have something.
Last updated: February 10, 2012: 07:26 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Greek cabinet approves new austerity plan, will vote on Sunday, CNBC reports
- CBOE Holdings to be added to S&P 400; Temple-Inland deleted as of 2/13 close
- Mylan announces unfavorable verdict in patent trial
- NYSE market internals summary
- NASDAQ market internals summary
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

